Add to ORKGpeer reviewedWe report a case of 1:1 flutter in a patient taking flecainide for atrial fibrillation. We discuss the mechanism of the arrhythmia, its treatment and the preventive attitude to be adopted
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
Summary: Twenty-eight patients with atrial fibrillation of less than 1 month's duration were gi...
The authors report the case of a patient with drug-resistant atrial fibrillation, who developed, for...
International audienceFlecainide is a class Ic antiarrhythmic agent that has an important role as pa...
Flecainide is reported to be effective in patients with paroxysmal tachycardias, but its effect on r...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...
In atrial flutter, chemical conversion with class I drugs is often unsuccessful, whereas class III d...
Over the last 35 years, flecainide proved itself one of the most commonly used arrhythmic drugs, exp...
Class Ic antiarrhythmic drugs are effective in the treatment of atrial fibrillation, but their mecha...
A 37-year-old man with symptomatic acute atrial fibrillation and a low-voltage electrocardiogram was...
Flecainide can increase QRS duration especially with tachycardia (positive use dependence) and organ...
Summary BACKGROUND: Flecainide, a class IC antiarrhythmic drug, is used frequently in patients wi...
Effective antiarrhythmic therapy requires a carefully considered approach, including an understandin...
acetate for refractory symptomatic supraventricular tachycardia. Six children had direct atrioventri...
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
Summary: Twenty-eight patients with atrial fibrillation of less than 1 month's duration were gi...
The authors report the case of a patient with drug-resistant atrial fibrillation, who developed, for...
International audienceFlecainide is a class Ic antiarrhythmic agent that has an important role as pa...
Flecainide is reported to be effective in patients with paroxysmal tachycardias, but its effect on r...
Anti-arrhythmic drugs (AADs) uniquely affect the various electrolyte channels in the heart and can s...
In atrial flutter, chemical conversion with class I drugs is often unsuccessful, whereas class III d...
Over the last 35 years, flecainide proved itself one of the most commonly used arrhythmic drugs, exp...
Class Ic antiarrhythmic drugs are effective in the treatment of atrial fibrillation, but their mecha...
A 37-year-old man with symptomatic acute atrial fibrillation and a low-voltage electrocardiogram was...
Flecainide can increase QRS duration especially with tachycardia (positive use dependence) and organ...
Summary BACKGROUND: Flecainide, a class IC antiarrhythmic drug, is used frequently in patients wi...
Effective antiarrhythmic therapy requires a carefully considered approach, including an understandin...
acetate for refractory symptomatic supraventricular tachycardia. Six children had direct atrioventri...
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
A 64-year-old female with paroxysmal atrial fibrillation presented to the emergency department with ...
Summary: Twenty-eight patients with atrial fibrillation of less than 1 month's duration were gi...